Silymarin: a review on paving the way towards promising pharmacological agent

References

• Newman, D. J.; Cragg, G. M. Natural Products as Sources of New Drugs from 1981 to 2014. J. Nat. Prod. 2016, 79(3), 629–661. DOI: 10.1021/acs.jnatprod.5b01055.
   PubMed Web of Science ®Google Scholar
• Tewari, D.; Nabavi, S. F.; Nabavi, S. M.; Sureda, A.; Farooqi, A. A.; Atanasov, A. G.; Bishayee, A.; Sethi, G.; Bishayee, A. Targeting Activator Protein 1 Signaling Pathway by Bioactive Natural Agents: Possible Therapeutic Strategy for Cancer Prevention and Intervention. Pharmacol. Res. 2016, 128, 366–375. DOI: 10.1016/j.phrs.2017.09.014.
   Web of Science ®Google Scholar
• Ferreira, I. C.; Martins, N.; Barros, L. Phenolic Compounds and Its Bioavailability: In vitro Bioactive Compounds or Health Promoters? Adv. Food Nutr. 2017, 82, 1–44. Academic Press
   PubMedGoogle Scholar
• Sapthasri, R. Silymarin Loaded Super Paramagnetic Iron Oxide Nanoparticle (SPIONS) for Targeting SARS COV-2 to Combat COVID-19 Doctoral dissertation, College of Pharmacy, Sri Ramakrishna Institute of Paramedical Sciences, Coimbatore. 2021.
   Google Scholar
• Porwal, O.; Ameen, M. S. M.; Anwer, E. T.; Uthirapathy, S.; Ahamad, J.; Tahsin, A. Silybum Marianum (Milk Thistle): Review on Its Chemistry, Morphology, Ethno Medical Uses, Phytochemistry and Pharmacological Activities. J. Drug Delivery Ther. 2019, 9(5), 199–206. DOI: 10.22270/jddt.v9i5.3666.
   Google Scholar
• Sporn, M. B.; Dunlop, N. M.; Newton, D. L.; Smith, J. M. Prevention of Chemical Carcinogenesis by Vitamin a and Its Synthetic Analogs (Retinoids). Fed. Proc. 1976, 35(6), 1332–1338.
   PubMedGoogle Scholar
• Melim, C.; Magalhães, M.; Santos, A. C.; Campos, E. J.; Cabral, C. Nanoparticles as Phytochemical Carriers for Cancer Treatment: News of the Last Decade. Expert Opin. Drug Delivery. 2022, 19(2), 179–197. DOI: 10.1080/17425247.2022.2041599.
   PubMed Web of Science ®Google Scholar
• Fanoudi, S.; Alavi, M. S.; Karimi, G.; Hosseinzadeh, H. Milk Thistle (Silybum Marianum) as an Antidote or a Protective Agent Against Natural or Chemical Toxicities: A Review. Drug Chem. Toxicol. 2019, 43(3), 240–254. DOI: 10.1080/01480545.2018.1485687.
   Web of Science ®Google Scholar
• Zarif-Yeganeh, M.; Rastegarpanah, M. Clinical Role of Silymarin in Oxidative Stress and Infertility: A Short Review for Pharmacy Practitioners. J. Res. Pharm. Pract. 2019, 8(4), 181. DOI: 10.4103/jrpp.JRPP_18_100.
   PubMed Web of Science ®Google Scholar
• Asrani, S. K.; Devarbhavi, H.; Eaton, J.; Kamath, P. S. Burden of Liver Diseases in the World. J. Hepatol. 2019, 70(1), 151–171. DOI: 10.1016/j.jhep.2018.09.014.
   PubMed Web of Science ®Google Scholar
• Clichici, S.; Olteanu, D.; Filip, A.; Nagy, A. L.; Oros, A.; Mircea, P. A. Beneficial Effects of Silymarin After the Discontinuation of CCl4-Induced Liver Fibrosis. J. Med. Food. 2016, 19(8), 789–797. DOI: 10.1089/jmf.2015.0104.
   PubMed Web of Science ®Google Scholar
• Marin, V.; Gazzin, S.; Gambaro, S. E.; Dal, B. M.; Calligaris, S.; Anese, M.; Rosso, N.; Avellini, C.; Giraudi, P.; Tiribelli, C. Effects of Oral Administration of Silymarin in a Juvenile Murine Model of Non-Alcoholic Steatohepatitis. Nutrients. 2017, 9(9), 1006. DOI: 10.3390/nu9091006.
   PubMed Web of Science ®Google Scholar
• Federico, A.; Dallio, M.; Loguercio, C. Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. Molecules. 2017, 22(2), 191. DOI: 10.3390/molecules22020191.
   PubMed Web of Science ®Google Scholar
• Adelina, J. A. M. Clinical Studies of Silymarin as a Protective Agent Against Liver Damage Caused by Anti-TB Drugs, Methotrexate, and in Cases of Chronic Hepatitis C and Diabetes Mellitus. Pharmacogn. J. 2022, 14(2), 358–368. DOI: 10.5530/pj.2022.14.46.
   Google Scholar
• Shavandi, M.; Yazdani, Y.; Asar, S.; Mohammadi, A.; Mohammadi-Noori, E.; Kiani, A. The Effect of Oral Administration of Silymarin on Serum Levels of Tumor Necrosis Factor-α and Interleukin-1ß in Patients with Rheumatoid Arthritis. Iran J. Immunol. 2022, 19(4), 427–435.
   PubMed Web of Science ®Google Scholar
• Won, D. H.; Kim, L. H.; Jang, B.; Yang, I. H.; Kwon, H. J.; Jin, B.; Cho, S. D.; Kang, J.-H.; Hong, S.-D.; Shin, J.-A. In vitro and in vivo Anti-Cancer Activity of Silymarin on Oral Cancer. Tumor Biol. 2018, 40(5), 101042831877617. DOI: 10.1177/1010428318776170.
   Google Scholar
• Karbasforooshan, H.; Hosseini, S.; Elyasi, S.; FaniPakdel, A.; Karimi, G. Topical Silymarin Administration for Prevention of Acute Radiodermatitis in Breast Cancer Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Phytother. Res. 2018, 33(2), 379–386. DOI: 10.1002/ptr.6231.
   PubMed Web of Science ®Google Scholar
• Tajmohammadi, A.; Razavi, B. M.; Hosseinzadeh, H. Silybum Marianum (Milk Thistle) and Its Main Constituent, Silymarin, as a Potential Therapeutic Plant in Metabolic Syndrome: A Review. Phytother. Res. 2018, 32(10), 1933–1949. DOI: 10.1002/ptr.6153.
   PubMed Web of Science ®Google Scholar
• Csupor, D.; Csorba, A.; Hohmann, J. Recent Advances in the Analysis of Flavonolignans of Silybum Marianum. J. Pharm. Biomed. Anal. 2016, 130, 301–317. DOI: 10.1016/j.jpba.2016.05.034.
   PubMed Web of Science ®Google Scholar
• Althagafy, H. S.; Meza-Aviña, M. E.; Oberlies, N. H.; Croatt, M. P. Mechanistic Study of the Biomimetic Synthesis of Flavonolignan Diastereoisomers in Milk Thistle. J. Org. Chem. 2013, 78(15), 7594–7600. DOI: 10.1021/jo4011377.
   PubMed Web of Science ®Google Scholar
• Surai, P. F. Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives. Antioxidants. 2015, 4(1), 204–247. DOI: 10.3390/antiox4010204.
   Web of Science ®Google Scholar
• Köksal, E.; Gülçin, I.; Beyza, S.; Sarikaya, O.; Bursal, E. In vitro Antioxidant Activity of Silymarin. J. Enzyme Inhib. Med. Chem. 2009, 24(2), 395–405. DOI: 10.1080/14756360802188081.
   PubMed Web of Science ®Google Scholar
• Salmond, S. J.; George, J.; Strasser, S. I.; Byth, K.; Rawlinson, B.; Mori, T. A.; Batey, R. G.; Adams, L.; Batey, R. Hep573 Study: A Randomised, Double-Blind, Placebocontrolled Trial of Silymarin Alone and Combined with Antioxidants to Improve Liver Function and Quality of Life in People with Chronic Hepatitis C. Aust. J. Herb. Naturop. Med. 2019, 31(2), 64–76. DOI: 10.33235//ajhnm.31.2.64-76.
   Google Scholar
• Tighe, S. P.; Akhtar, D.; Iqbal, U.; Ahmed, A. Chronic Liver Disease and Silymarin: A Biochemical and Clinical Review. J. Clin. Transl. Hepatol. 2020, 8(4), 454. DOI: 10.14218/JCTH.2020.00012.
   PubMed Web of Science ®Google Scholar
• Walczak–Jedrzejowska, R.; Wolski, J. K.; Slowikowska–Hilczer, J. The Role of Oxidative Stress and Antioxidants in Male Fertility. Cent. European J. Urol. 2013, 66(1), 60. DOI: 10.5173/ceju.2013.01.art19.
   PubMedGoogle Scholar
• Kamkar, N.; Ramezanali, F.; Sabbaghian, M. The Relationship Between Sperm DNA Fragmentation, Free Radicals and Antioxidant Capacity with Idiopathic Repeated Pregnancy Loss. Reprod. Biol. 2018, 18(4), 330–335. DOI: 10.1016/j.repbio.2018.11.002.
   PubMed Web of Science ®Google Scholar
• Darbandi, M.; Darbandi, S.; Agarwal, A.; Sengupta, P.; Durairajanayagam, D.; Henkel, R.; Sadeghi, M. R. Reactive Oxygen Species and Male Reproductive Hormones. Reprod. Reprod Biol.Endocrinol. 2018, 16(1), 1–14. DOI: 10.1186/s12958-018-0406-2.
   PubMedGoogle Scholar
• Dutta, S.; Sengupta, P.; Slama, P.; Roychoudhury, S. Oxidative Stress, Testicular Inflammatory Pathways, and Male Reproduction. Int. J. Mol. Sci. 2021, 22(18), 10043. DOI: 10.3390/ijms221810043.
   PubMed Web of Science ®Google Scholar
• Said, T. M.; Gokul, S. R.; Agarwal, A. Clinical Consequences of Oxidative Stress in Male Infertility. In Studies on Men’s Health and Fertility. Humana Press. 2012; pp. 535–549. DOI: 10.1007/978-1-61779-776-7_24.
   Google Scholar
• Tremellen, K. Oxidative Stress and Male Infertility—A Clinical Perspective. Hum. Reprod. Update. 2008, 14(3), 243–258. DOI: 10.1093/humupd/dmn004.
   PubMed Web of Science ®Google Scholar
• Bisht, S.; Faiq, M.; Tolahunase, M.; Dada, R. Oxidative Stress and Male Infertility. Nat. Rev. Urol. 2017, 14(8), 470–485. DOI: 10.1038/nrurol.2017.69.
   PubMed Web of Science ®Google Scholar
• García-Rodríguez, A.; Gosálvez, J.; Agarwal, A.; Roy, R.; Johnston, S. DNA Damage and Repair in Human Reproductive Cells. Int. J. Mol. Sci. 2018, 20(1), 31. DOI: 10.3390/ijms20010031.
   PubMed Web of Science ®Google Scholar
• Aprotosoaie, A. C.; Luca, V. S.; Trifan, A.; Miron, A. Antigenotoxic Potential of Some Dietary Non-Phenolic Phytochemicals. Studi. Nat. Prod. Chem. 2019, 60, 223–297.
   Google Scholar
• Etemadi, T.; Momeni, H. R.; Ghafarizadeh, A. A. Impact of Silymarin on Cadmium‐Induced Apoptosis in Human Spermatozoa. Andrologia. 2020, 52(11), e13795. DOI: 10.1111/and.13795.
   PubMed Web of Science ®Google Scholar
• Eskandari, F.; Momeni, H. R. Protective Effect of Silymarin on Viability, Motility and Mitochondrial Membrane Potential of Ram Sperm Treated with Sodium Arsenite. Int. J. Reprod. BioMed. 2016, 14(6), 397. DOI: 10.29252/ijrm.14.6.397.
   PubMed Web of Science ®Google Scholar
• Roostaei‐Ali Mehr, M.; Parisoush, P. Effect of Different Levels of Silymarin and Caproic Acid on Storage of Ram Semen in Liquid Form. Reprod. Domest. Anim. 2016, 51(4), 569–574. DOI: 10.1111/rda.12721.
   PubMed Web of Science ®Google Scholar
• El-Sheshtawy, R. I.; El-Nattat, W. S. Impact of Silymarin Enriched Semen Extender on Bull Sperm Preservability. Asian Pac. J. Reprod. 2017, 6(2), 81. DOI: 10.12980/apjr.6.20170206.
   Google Scholar
• Oufi, H. G.; Al-Shawi, N. N.; Hussain, S. A. What are the Effects of Silibinin on Testicular Tissue of Mice? J. App. Pharm. Sci. 2012, 2, 009–013.
   Google Scholar
• Abedi, H.; Jahromi, H. K.; Hashemi, S. A.; Jashni, H. K.; Jahromi, Z. K.; Pourahmadi, M. The Effect of Silymarin on Spermatogenesis Process in Rats. Int. Sci. J. Med. Res. Health Sci. 2016, 5, 146–150.
   Google Scholar
• El-Hanbuli, H. M.; Abo-Sief, A. F.; Mostafa, T. Protective Effect of Silymarin on the Testes of Rats Treated with Anabolic Androgenic Steroid: A Biochemical, Histological, Histochemical and Immunohistochemical Study. Histol. Histopathol. 2017, 4(1), 10. DOI: 10.7243/2055-091X-4-10.
   Google Scholar
• Attia, Y. A.; Hamed, R. S.; Bovera, F.; Abd El, A. E. H. E.; Al-Harthi, M. A.; Shahba, H. A. Semen Quality, Antioxidant Status and Reproductive Performance of Rabbits Bucks Fed Milk Thistle Seeds and Rosemary Leaves. Anim. Reprod. Sci. 2017, 184, 178–186. DOI: 10.1016/j.anireprosci.2017.07.014.
   PubMed Web of Science ®Google Scholar
• Pourheydar, B.; Azarm, F.; Farjah, G.; Karimipour, M.; Pourheydar, M. Effect of Silymarin and Metformin on the Sperm Parameters and Histopathological Changes of Testes in Diabetic Rats: An Experimental Study. Int. J. Reprod. BioMed. 2021, 19(12), 1091. DOI: 10.18502/ijrm.v19i12.10060.
   PubMed Web of Science ®Google Scholar
• Mazhari, S.; Razi, M.; Malekinejad, H.; Sadrkhanlou, R. Celecoxib and Silymarin Attenuated Varicocele-Induced Damages at Testicular and Sperm Levels; Evidence for Endocrine and Antioxidant Statuses. Int. J. Reprod. BioMed. 2014, 12(6), 117.
   Google Scholar
• Moshtaghion, S. M.; Malekinejad, H.; Razi, M.; Shafie-Irannejad, V. Silymarin Protects from Varicocele-Induced Damages in Testis and Improves Sperm Quality: Evidence for E2f1 Involvement. Syst. Biol. Reprod. Med. 2013, 59(5), 270–280. DOI: 10.3109/19396368.2013.794253.
   PubMed Web of Science ®Google Scholar
• Fatehi, D.; Mohammadi, M.; Shekarchi, B.; Shabani, A.; Seify, M.; Rostamzadeh, A. Radioprotective Effects of Silymarin on the Sperm Parameters of NMRI Mice Irradiated with γ-Rays. J. Photochem. Photobiol. B, Biol. 2018, 178, 489–495. DOI: 10.1016/j.jphotobiol.2017.12.004.
   PubMed Web of Science ®Google Scholar
• Marzban, M.; Anjamshoa, M.; Jafari, P.; Masoumi, H.; Ahadi, R.; Fatehi, D. Effects of Gamma Rays on Rat Testis Tissue According to the Morphological Parameters and Immunohistochemistry: Radioprotective Role of Silymarin. Electron. Physician. 2017, 9(6), 4524. DOI: 10.19082/4524.
   PubMedGoogle Scholar
• Sheweita, S. A.; Al-Shora, S.; Hassan, M. Effects of Benzo [A] Pyrene as an Environmental Pollutant and Two Natural Antioxidants on Biomarkers of Reproductive Dysfunction in Male Rats. Environ. Sci. Pollut. Res. Environ. Sci. Pollut. R. 2016, 23(17), 17226–17235. DOI: 10.1007/s11356-016-6934-4.
   PubMed Web of Science ®Google Scholar
• Yaman, T.; Uyar, A.; Kaya, M. S.; Keles, Ö. F.; Uslu, B. A.; Yener, Z. Protective Effects of Silymarin on Methotrexate-Induced Damages in Rat Testes. Braz. J. Pharm. Sci. 2018, 54(1), 54. DOI: 10.1590/s2175-97902018000117529.
   Web of Science ®Google Scholar
• JANBAZ, A. H.; Malekinejad, H.; Sadrrkhanlou, R. A.; Razi, M. Silymarin Prevents and Protects from the Doxorubicin-Induced Oxidative Stress in Testis and Improves Sperm Quality in Rats. Int. J. Fertil. Steril. 2012, 6, 61.
   Google Scholar
• Ali, W. D.; Khudair, A. R.; AL-Masoudi, E. A. Ameliorative Role of Silymarin Extracted from Silybum Marianum Seeds on Nickel Chloride Induce Changes in Testicular Functions in Adult Male Rabbits. Basra. J. Vet. Res. 2015, 14(1), 135–144. DOI: 10.33762/bvetr.2015.99994.
   Google Scholar
• Khazaei, R.; Seidavi, A.; Bouyeh, M. A Review on the Mechanisms of the Effect of Silymarin in Milk Thistle (Silybum Marianum) on Some Laboratory Animals. Vet. Med. Sci. 2022, 8(1), 289–301. DOI: 10.1002/vms3.641.
   PubMed Web of Science ®Google Scholar
• Manokaran, K.; Bhat, P.; Nayak, D.; Baskaran, R.; Paramasivam, P.; Ahmed, S. F.; Balaji, V. E.; Ranganath Pai, K.; Balaji, V. Oxidative Stress and Female Reproductive Disorder: A Review. Asian Pac. J. Reprod. 2022, 11(3), 107–116. DOI: 10.4103/2305-0500.346088.
   Web of Science ®Google Scholar
• Zeng, L. H.; Rana, S.; Hussain, L.; Asif, M.; Mehmood, M. H.; Imran, I.; Abed, S. N.; Mahdy, A.; Al-Joufi, F. A.; Abed, S. N. Polycystic Ovary Syndrome: A Disorder of Reproductive Age, Its Pathogenesis, and a Discussion on the Emerging Role of Herbal Remedies. Front Pharmacol. 2022, 13, 874914. DOI: 10.3389/fphar.2022.874914.
   PubMed Web of Science ®Google Scholar
• Hariyanti, T.; Margiana, R.; Al-Gazally, M. E.; Patra, I.; Lateef Al-Awsi, G. R.; Hameed, N.; Farhood, B.; Ansari, M. J.; Torres-Criollo, L. M.; Mustafa, Y. F. The Protective Effects of Silymarin on the Reproductive Toxicity: A Comprehensive Review. Curr. Med. Chem. 2023, 30(39), 4421–4449. DOI: 10.2174/0929867330666230130115332.
   PubMed Web of Science ®Google Scholar
• Naji, T.; Ghafouri, S.; Sahafi, H. H. The Histological Effects of Cucurbita Pepo, Silybum Marianum, Linum Usitatissmum, Vitex Agnus-Castus 17β Estradiol on Ovarian Tissue in Three Spot Gorami (Trichogaster Trichopterus). Bull. Environ. Pharmacol. Life Sci. 2014, 3, 120–127.
   Google Scholar
• Neha; Jaggi, A. S.; Singh, N. Silymarin and Its Role in Chronic Diseases. Nat. Rev. Drug Discov. 2016, 25–44.
   Google Scholar
• Turk, P.; Kuspinar, G.; Ozerkan, K.; Avci, B. Protective Effect of Silymarin on Cyclophosphamide Toxicity in Ovarian Tissue. Fertil. Steril. 2016, 106(3), e125. DOI: 10.1016/j.fertnstert.2016.07.375.
   Web of Science ®Google Scholar
• Iqbal, U.; Perumpail, B. J.; Akhtar, D.; Kim, D.; Ahmed, A. The Epidemiology, Risk Profiling and Diagnostic Challenges of Nonalcoholic Fatty Liver Disease. J. Med. 2019, 6(1), 41. DOI: 10.3390/medicines6010041.
   Google Scholar
• Asrani, S. K.; Hall, L.; Hagan, M.; Sharma, S.; Yeramaneni, S.; Trotter, J.; Talwalkar, J.; Kanwal, F. Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study. Am. J. Gastroenterol. 2019, 114(1), 98–106. DOI: 10.1038/s41395-018-0365-4.
   PubMed Web of Science ®Google Scholar
• Kim, D.; Li, A. A.; Gadiparthi, C.; Khan, M. A.; Cholankeril, G.; Glenn, J. S.; Ahmed, A. Changing Trends in Etiology-Based Annual Mortality from Chronic Liver Disease, from 2007 Through 2016. Gastroenterol. 2018, 155(4), 1154–1163. DOI: 10.1053/j.gastro.2018.07.008.
   PubMed Web of Science ®Google Scholar
• Abenavoli, L.; Izzo, A. A.; Milić, N.; Cicala, C.; Santini, A.; Capasso, R. Milk Thistle (Silybum Marianum): A Concise Overview on Its Chemistry, Pharmacological, and Nutraceutical Uses in Liver Diseases. Phytother Res. 2018, 32(11), 2202–2213. DOI: 10.1002/ptr.6171.
   PubMed Web of Science ®Google Scholar
• Ghorbani, Z.; Hajizadeh, M.; Hekmatdoost, A. Dietary Supplementation in Patients with Alcoholic Liver Disease: A Review on Current Evidence. Hepatobiliary Pancreat. Dis. Int. 2016, 15(4), 348–360. DOI: 10.1016/S1499-3872(16)60096-6.
   PubMed Web of Science ®Google Scholar
• Salmi, H. A.; Sarna, S. Effect of Silymarin on Chemical, Functional, and Morphological Alterations of the Liver: A Double-Blind Controlled Study. Scand J. Gastroenterol. 1982, 17(4), 517–521. DOI: 10.3109/00365528209182242.
   PubMed Web of Science ®Google Scholar
• Feher, J.; Deák, G.; Müzes, G.; Lang, I.; Niederland, V.; Nekam, K.; Karteszi, M. Liver-Protective Action of Silymarin Therapy in Chronic Alcoholic Liver Diseases. Orvosi hetilap. 1989, 130(51), 2723–2727.
   PubMedGoogle Scholar
• Gillessen, A.; Schmidt, H. H. J. Silymarin as Supportive Treatment in Liver Diseases: A Narrative Review. Adv. Ther. 2020, 37(4), 1279–1301. DOI: 10.1007/s12325-020-01251-y.
   PubMed Web of Science ®Google Scholar
• Zhong, S.; Fan, Y.; Yan, Q.; Fan, X.; Wu, B.; Han, Y.; Zhang, Y.; Chen, Y.; Zhang, H.; Niu, J. The Therapeutic Effect of Silymarin in the Treatment of Nonalcoholic Fatty Disease: A Meta-Analysis (PRISMA) of Randomized Control Trials. Medicine. 2017, 96(49), e9061. DOI: 10.1097/MD.0000000000009061.
   PubMed Web of Science ®Google Scholar
• Shakya, A. K. Drug-Induced Hepatotoxicity and Hepatoprotective Medicinal Plants: A Review. Indian J. Pharm. Educ. Res. 2020, 54(2), 234–250. DOI: 10.5530/ijper.54.2.28.
   Web of Science ®Google Scholar
• Soleimani, V.; Delghandi, P. S.; Moallem, S. A.; Karimi, G. Safety and Toxicity of Silymarin, the Major Constituent of Milk Thistle Extract: An Updated Review. Phytother Res. 2019, 33(6), 1627–1638. DOI: 10.1002/ptr.6361.
   PubMed Web of Science ®Google Scholar
• de Avelar, C. R.; Pereira, E. M.; de Farias Costa, P. R.; de Jesus, R. P.; de Oliveira, L. P. M. Effect of Silymarin on Biochemical Indicators in Patients with Liver Disease: Systematic Review with Meta-Analysis. WJG, World J. Gastroenterol. 2017, 23(27), 5004. DOI: 10.3748/wjg.v23.i27.5004.
   PubMed Web of Science ®Google Scholar
• Villanueva-Paz, M.; Morán, L.; López-Alcántara, N.; Freixo, C.; Andrade, R. J.; Lucena, M. I.; Cubero, F. J. Oxidative Stress in Drug-Induced Liver Injury (DILI): From Mechanisms to Biomarkers for Use in Clinical Practice. Antioxidants. 2021, 10(3), 390. DOI: 10.3390/antiox10030390.
   Web of Science ®Google Scholar
• Javed, S.; Ahsan, W.; Kohli, K. Pharmacological Influences of Natural Products as Bioenhancers of Silymarin Against Carbon Tetrachloride-Induced Hepatotoxicity in Rats. Clin. Phytoscience. 2018, 4(1), 1–9. DOI: 10.1186/s40816-018-0079-6.
   Google Scholar
• Oghenevwodoko Okoro, I.; Ejiro Kadiri, H. Anti-Oxidant and Hepatoprotective Effects of Senecio Biafrae on CCl4-Induced Liver Damage in Rats. Iran. J. Toxicol. 2019, 13(2), 31–35. DOI: 10.32598/IJT.13.2.583.1.
   Google Scholar
• Barbaro, D.; Di Lorenzo, G.; Soldini, M.; Parrotto, S.; Bellomo, G.; Belloni, G.; Barbarini, G. Hepatic Glutathione Deficiency in Chronic Hepatitis C: Quantitative Evaluation in Patients Who are HIV Positive and HIV Negative and Correlations with Plasmatic and Lymphocytic Concentrations and with the Activity of the Liver Disease. Am. J. Gastroenterol. Suppl. (Springer Nature). 1996, 91(12), 2569–2573.
   PubMed Web of Science ®Google Scholar
• Lieber, C. S.; Leo, M. A.; Cao, Q.; Ren, C.; DeCarli, L. M. Silymarin Retards the Progression of Alcohol-Induced Hepatic Fibrosis in Baboons. J. Clin. Gastroenterol. 2003, 37(4), 336–339. DOI: 10.1097/00004836-200310000-00013.
   PubMed Web of Science ®Google Scholar
• Abd Elmaaboud, M.; Khattab, H.; Shalaby, S. Hepatoprotective Effect of Linagliptin Against Liver Fibrosis Induced by Carbon Tetrachloride in Mice. Can. J. Physiol. Pharmacol. 2021, 99(3), 294–302. DOI: 10.1139/cjpp-2020-0049.
   PubMed Web of Science ®Google Scholar
• Okda, T. M.; Abd-Alhaseeb, M. M.; Barka, K.; Ragab, N. M. Ginger Potentiates the Effects of Silymarin on Liver Fibrosis Induced by CCL4: The Role of Galectin-8. Eu.R Rev. Med. Pharmacol. Sci. 2019, 23(2), 885–891.
   PubMed Web of Science ®Google Scholar
• Melaibari, M.; Alkreathy, H. M.; Esmat, A.; Rajeh, N. A.; Shaik, R. A.; Alghamdi, A. A.; Ahmad, A. Anti-Fibrotic Efficacy of Apigenin in a Mice Model of Carbon Tetrachloride-Induced Hepatic Fibrosis by Modulation of Oxidative Stress, Inflammation, and Fibrogenesis: A Preclinical Study. Biomedicines. 2023, 11(5), 1342. DOI: 10.3390/biomedicines11051342.
   PubMed Web of Science ®Google Scholar
• Owona, B. A.; Abia, W. A.; Moundipa, P. F. Natural Compounds Flavonoids as Modulators of Inflammasomes in Chronic Diseases. Int. Immunopharmacol. 2020, 84, 106498. DOI: 10.1016/j.intimp.2020.106498.
   PubMed Web of Science ®Google Scholar
• Akhtar, D. H.; Iqbal, U.; Vazquez-Montesino, L. M.; Dennis, B. B.; Ahmed, A. Pathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease. J.C.T.H. 2019, 7(4), 362. DOI: 10.14218/JCTH.2019.00028.
   Google Scholar
• Esmaeil, N.; Anaraki, S. B.; Gharagozloo, M.; Moayedi, B. Silymarin Impacts on Immune System as an Immunomodulator: One Key for Many Locks. Int. Immunopharmacol. 2017, 50, 194–201. DOI: 10.1016/j.intimp.2017.06.030.
   PubMed Web of Science ®Google Scholar
• Serviddio, G.; Bellanti, F.; Stanca, E.; Lunetti, P.; Blonda, M.; Tamborra, R.; Giudetti, A. M.; Vendemiale, G.; Capobianco, L.; Giudetti, A. M. Silybin Exerts Antioxidant Effects and Induces Mitochondrial Biogenesis in Liver of Rat with Secondary Biliary Cirrhosis. Free Radic Biol. Med. 2014, 73, 117–126. DOI: 10.1016/j.freeradbiomed.2014.05.002.
   PubMed Web of Science ®Google Scholar
• Fried, M. W.; Navarro, V. J.; Afdhal, N.; Belle, S. H.; Wahed, A. S.; Hawke, R. L.; Reddy, K. R. Effect of Silymarin (Milk Thistle) on Liver Disease in Patients with Chronic Hepatitis C Unsuccessfully Treated with Interferon Therapy: A Randomized Controlled Trial. JAMA. 2012, 308(3), 274–282. DOI: 10.1001/jama.2012.8265.
   PubMed Web of Science ®Google Scholar
• Hawke, R. L.; Schrieber, S. J.; Soule, T. A.; Wen, Z.; Smith, P. C.; Reddy, K. R.; Fried, M. W.; Belle, S. H.; Afdhal, N. H.; Navarro, V. J. Silymarin Ascending Multiple Oral Dosing Phase I Study in Noncirrhotic Patients with Chronic Hepatitis C. J. Clin. Pharmacol. 2010, 50(4), 434–449. DOI: 10.1177/0091270009347475.
   PubMed Web of Science ®Google Scholar
• Malaguarnera, G.; Bertino, G.; Chisari, G.; Motta, M.; Vecchio, M.; Vacante, M.; Malaguarnera, M.; Greco, C.; Drago, F.; Nunnari, G., et al. Silybin Supplementation During HCV Therapy with Pegylated Interferon-α Plus Ribavirin Reduces Depression and Anxiety and Increases Work Ability. BMC Psychiatry. 2016, 16(1), 398. DOI: 10.1186/s12888-016-1115-z.
   PubMedGoogle Scholar
• Rutter, K.; Scherzer, T. M.; Beinhardt, S.; Kerschner, H.; Stättermayer, A. F.; Hofer, H.; Ferenci, P.; Steindl-Munda, P.; Ferenci, P. Intravenous Silibinin as ‘Rescue Treatment’ for On-Treatment Non-Responders to Pegylated Interferon/Ribavirin Combination Therapy. Antiviral Ther. 2011, 16(8), 1327–1333. DOI: 10.3851/IMP1942.
   PubMed Web of Science ®Google Scholar
• Kalantari, H.; Shahshahan, Z.; Hejazi, S. M.; Ghafghazi, T.; Sebghatolahi, V. Effects of Silybum Marianum on Patients with Chronic Hepatitis C. J. Res. Med. Sci. 2011, 16(3), 287–290.
   PubMed Web of Science ®Google Scholar
• Biermer, M.; Schlosser, B.; Fülöp, B.; van Bömmel, F.; Brodzinski, A.; Heyne, R.; Keller, K.; Sarrazin, C.; Berg, T. High-Dose Silibinin Rescue Treatment for HCV-Infected Patients Showing Suboptimal Virologic Response to Standard Combination Therapy. J. Viral Hepat. 2012, 19(8), 547–553. DOI: 10.1111/j.1365-2893.2011.01572.x.
   PubMed Web of Science ®Google Scholar
• Luangchosiri, C.; Thakkinstian, A.; Chitphuk, S.; Stitchantrakul, W.; Petraksa, S.; Sobhonslidsuk, A. A Double-Blinded Randomized Controlled Trial of Silymarin for the Prevention of Antituberculosis Drug-Induced Liver Injury. BMC Complementary Altern. Med. 2015, 15(1), 334. DOI: 10.1186/s12906-015-0861-7.
   PubMed Web of Science ®Google Scholar
• Heo, E.; Kim, D. K.; Oh, S. H.; Lee, J. K.; Park, J. H.; Chung, H. S. Effect of Prophylactic Use of Silymarin on Anti-Tuberculosis Drugs Induced Hepatotoxicity. Tuberc Respir. Dis. 2017, 80(3), 265–269. DOI: 10.4046/trd.2017.80.3.265.
   PubMed Web of Science ®Google Scholar
• Marjani, M.; Baghaei, P.; KazempourDizaji, M.; GorjiBayani, P.; Fahimi, F.; Tabarsi, P.; Velayati, A. A. Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial. Iran J. Pharm. Res. 2016, 15(1), 247–252.
   PubMed Web of Science ®Google Scholar
• Hughes, C.; Hydrie, M. Z. I.; Vohra, S. Interactions Between Antiretrovirals and Natural Health Products. In Health of HIV Infected People. Academic Press. 2015; pp. 255–273. DOI: 10.1016/B978-0-12-800769-3.00015-9.
   Google Scholar
• Momeni, A.; Hajigholami, A.; Geshnizjani, S.; Soleiman, K. Effect of Silymarin in the Prevention of Cisplatin Nephrotoxicity, a Clinical Trial Study. J. Clin. Diagnostic Res. 2015, 9(4), OC11–OC13. DOI: 10.7860/JCDR/2015/12776.5789.
   PubMed Web of Science ®Google Scholar
• Shahbazi, F.; Sadighi, S.; Dashti-Khavidaki, S.; Shahi, F.; Mirzania, M.; Abdollahi, A.; Ghahremani, M. H. Effect of Silymarin Administration on Cisplatin Nephrotoxicity: Report from a Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Phytother. Res. 2015, 29(7), 1046–1053. DOI: 10.1002/ptr.5345.
   PubMed Web of Science ®Google Scholar
• Flaig, T. W.; Gustafson, D. L.; Su, L. J.; Zirrolli, J. A.; Crighton, F.; Harrison, G. S.; Glodé, L. M.; Agarwal, R.; Glodé, L. M. A Phase I and Pharmacokinetic Study of Silybin-Phytosome in Prostate Cancer Patients. Invest. New Drugs. 2007, 25(2), 139–146. DOI: 10.1007/s10637-006-9019-2.
   PubMed Web of Science ®Google Scholar
• Elyasi, S.; Shojaee, F. S. R.; Allahyari, A.; Karimi, G. Topical Silymarin Administration for Prevention of Capecitabine-Induced Hand-Foot Syndrome: A Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Phytother. Res. 2017, 31(9), 1323–1329. DOI: 10.1002/ptr.5857.
   PubMed Web of Science ®Google Scholar
• Belli, V.; Sforza, V.; Cardone, C.; Martinelli, E.; Barra, G.; Matrone, N.; Troiani, T.; Morgillo, F.; Tuccillo, C.; Federico, A. Regorafenib in Combination with Silybin as a Novel Potential Strategy for the Treatment of Metastatic Colorectal Cancer. Oncotarget. 2017, 8(40), 68305–68316. DOI: 10.18632/oncotarget.20054.
   PubMedGoogle Scholar
• Mastron, J. K.; Siveen, K. S.; Sethi, G.; Bishayee, A. Silymarin and Hepatocellular Carcinoma: A Systematic, Comprehensive, and Critical Review. Anti-Cancer Drugs. 2015, 26(5), 475–486. DOI: 10.1097/CAD.0000000000000211.
   PubMed Web of Science ®Google Scholar
• Hussain, S. A.; Mortada, A. H.; Jasim, N. A.; Gorial, F. I. Silibinin Improves the Effects of Methotrexate in Patients with Active Rheumatoid Arthritis: Pilot Clinical Study. Oman Med. J. 2016, 31(4), 263–269. DOI: 10.5001/omj.2016.52.
   PubMedGoogle Scholar
• Atarbashe, R. K.; Abu-Raghif, A. The Therapeutic Effects of Ambrisentan on Experimentally Induced Colitis in a Male Rat’s Models. Ann Trop Med. Public Health. 2020, 23(4). DOI: 10.36295/ASRO.2020.23411.
   Google Scholar
• Rastegarpanah, M.; Malekzadeh, R.; Vahedi, H.; Mohammadi, M.; Elahi, E.; Chaharmahali, M.; Safarnavadeh, T.; Abdollahi, M. A Randomized, Double Blinded, Placebo-Controlled Clinical Trial of Silymarin in Ulcerative Colitis. Chin. J. Integr. Med. 2015, 21(12), 902–906. DOI: 10.1007/s11655-012-1026-x.
   PubMed Web of Science ®Google Scholar
• Hoseini, M.; Mohammadi, S.; Mohammadi-Hamaneh, A.; Akbarzadeh, T.; Abdollahi, A.; Jaafari, M. R.; Rezayat, S. M. An Experimental Model on the Protective Impact of Nanosilymarin on Ulcerative Colitis Induced by TNBS in Rats: The Inclusion of TLR4/NF-Κb Pathway. Nanomed. J. 2022, 9(3), 216–222Z.
   Google Scholar
• Cheema, H. S.; Singh, M. P. The Use of Medicinal Plants in Digestive System Related Disorders—A Systematic Review. J. Ayurvedic Herb. Med. 2021, 7(3), 182–187. DOI: 10.31254/jahm.2021.7303.
   Google Scholar
• Di Pierro, F.; Bellone, I.; Rapacioli, G.; Putignano, P. Clinical Role of a Fixed Combination of Standardized Berberis Aristata and Silybum Marianum Extracts in Diabetic and Hypercholesterolemic Patients Intolerant to Statins. Diabetes Metab. Syndr. Obes. 2015, 8, 89–96. DOI: 10.2147/DMSO.S78877.
   PubMed Web of Science ®Google Scholar
• EbrahimpourKoujan, S.; Gargari, B. P.; Mobasseri, M.; Valizadeh, H.; Asghari-Jafarabadi, M. Effects of Silybum Marianum (L.) Gaertn. (Silymarin) Extract Supplementation on Antioxidant Status and Hs-CRP in Patients with Type 2 Diabetes Mellitus: A Randomized, Triple-Blind, Placebo-Controlled Clinical Trial. Phytomed. 2015, 22(2), 290–296. DOI: 10.1016/j.phymed.2014.12.010.
   PubMed Web of Science ®Google Scholar
• Hagag, A. A.; Elfaragy, M. S.; Elrifaey, S. M.; Abd El-Lateef, A. E. Therapeutic Value of Combined Therapy with Deferiprone and Silymarin as Iron Chelators in Egyptian Children with Beta Thalassemia Major. Infect. Disord. Drug Targets. 2015, 15(3), 189–195. DOI: 10.2174/1871526515666150731113305.
   PubMedGoogle Scholar
• Moayedi, B.; Gharagozloo, M.; Esmaeil, N.; Maracy, M. R.; Hoorfar, H.; Jalaeikar, M. A Randomized Double-Blind, Placebo-Controlled Study of Therapeutic Effects of Silymarin in β-Thalassemia Major Patients Receiving Desferrioxamine. IEur. J. Haematol. 2013, 90(3), 202–209. DOI: 10.1111/ejh.12061.
   PubMed Web of Science ®Google Scholar
• Balouchi, S.; Gharagozloo, M.; Esmaeil, N.; Mirmoghtadaei, M.; Moayedi, B. Serum Levels of TGFβ, IL-10, IL-17, and IL-23 Cytokines in β-Thalassemia Major Patients: The Impact of Silymarin Therapy. Immunopharmacol. Immunotoxicol. 2014, 36(4), 271–274. DOI: 10.3109/08923973.2014.926916.
   PubMed Web of Science ®Google Scholar
• DarvishiKhezri, H.; Salehifar, E.; Kosaryan, M.; Aliasgharian, A.; Jalali, H.; HadianAmree, A. Potential Effects of Silymarin and Its Flavonolignan Components in Patients with β-Thalassemia Major: A Comprehensive Review in 2015. Adv. Pharmacol. Sci. 2016, 2016, 1–8. DOI: 10.1155/2016/3046373.
   Google Scholar
• Hutchinson, C.; Bomford, A.; Geissler, A. C. The Iron-Chelating Potential of Silybin in Patients with Hereditary Haemochromatosis. Eur. J. Clin. Nutr. 2010, 64(10), 1239–1241. DOI: 10.1038/ejcn.2010.136.
   PubMed Web of Science ®Google Scholar